Compounds of Formula (0), and stereoisomers and pharmaceutically acceptable salts thereof, as well as methods of use as Interleukin-1 Receptor Associated Kinase (IRAK4) inhibitors are described herein.
本文描述了公式(0)的化合物,以及其立体异构体和药用可接受的盐,以及作为白细胞介素-1受体相关激酶(IRAK4)
抑制剂的使用方法。